How Biological Therapies Are Transforming EGPA Treatment
Eosinophilic Granulomatosis with Polyangiitis (EGPA) presents a challenging landscape in autoimmune disease management, with its complex organ involvement and diagnostic difficulties. Traditional treatments like corticosteroids often fall short, prompting a shift towards innovative biological therapies. Advances with agents like mepolizumab and benralizumab promise reduced steroid reliance and improved remission rates. As the treatment landscape evolves, […]
3 minute read